4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1
Description
In recent years, especially since the outbreak of the severe acute respiratory syndrome coronavirus 2 pandemic, the cell-permeable itaconate derivative 4-octyl itaconate (4-OI) has gained traction as a potential antiviral agent. Here, we demonstrate
